SOURCE: Research and Markets

Research and Markets

April 05, 2016 11:22 ET

Next-Generation Glycemic Control Therapeutics Report 2015 -- What Drugs Are Expected to Enter the Market in the Next Five Years, and What Will Be Their Probable Impact on the Overall Market?

DUBLIN, IRELAND --(Marketwired - April 05, 2016) - Research and Markets has announced the addition of the "Next-Generation Glycemic Control Therapeutics" report to their offering.

As the number of patients diagnosed with diabetes continues to climb worldwide, drug developers and researchers are attempting for find more effective ways to control glucose levels, particularly for Type 2 diabetics. These efforts have led to a growing list of GLP-1 agonists and DPP-4 inhibitors that have been approved or are in late stage clinical development.

New medicines based on novel therapeutic moieties and potentially unique benefits are attracting attention and research investment. The result is an evolving therapeutic landscape that is providing clinicians and patients with new ways to manage their diabetes. For market participants, product positioning and prescriber training will become increasingly important as competitive threats remain fluid.


  • What therapeutic drugs are currently marketed for glycemic control, how are they administered, who markets them, and what is the size of the global market?
  • What are the important factors in patient self-administration of glycemic drugs, what are the current prescribing trends, and what are the key factors influencing demand?
  • What are the regional factors affecting market size and demand?
  • What are the new classes of drugs that are entering the market for treating diabetes, what is their market share and what are their growth prospects?
  • What drugs are expected to enter the market in the next five years, and what will be their probable impact on the overall market?
  • What are the significant economic, technology, and regulatory factors affecting the market for glycemic control therapeutics?

Key Topics Covered:

1. Executive Summary

2. The Market Opportunity

3. Approved Next-Generation Therapeutics

4. Development-stage Glycemic Control Products

5. Market Data and Forecasts

6. Market Factors

7. Company Profiles

For more information visit

Sector: Pharmaceuticals

Image Available:

Contact Information

  • Research and Markets
    Laura Wood
    Senior Manager

    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900

    U.S. Fax: 646-607-1907
    Fax (outside U.S.): +353-1-481-1716